| 5500 |
Centers for Disease Control and Prevention |
Html |
en |
1-Hexadecanethiol - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 5980 |
Centers for Disease Control and Prevention |
Html |
en |
Asbestos - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6265 |
Centers for Disease Control and Prevention |
Html |
null |
FASD - Free Materials |
FASDs are 100% preventable if a woman does not drink alcohol during pregnancy. There is no known safe amount of alcohol to drink while pregnant. There is also no safe time during pregnancy to drink and no safe kind of alcohol. |
|
|
CLICK HERE |
| 9731 |
Centers for Disease Control and Prevention |
Html |
es |
La historia de Tiffany - Historias de la vida real - Consejos de exfumadores |
La historia de Tiffany, un ex fumador que dejó de fumar con éxito, es parte de la campaña Consejos de exfumadores de los CDC. |
| Archivo Apple Quicktime | 0.645811 |
| Archivo RealPlayer | 0.532636 |
| Archivo Zip Comprimido | 0.639856 |
| Archivo Microsoft PowerPoint | 0.66247 |
|
| Archivo Microsoft Excel | 0.647934 |
| Archivo Adobe PDF | 0.63089 |
| Archivo Microsoft | 0.911091 |
|
CLICK HERE |
| 10108 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Effect of a Liver Cancer Education Program on Hepatitis B Screening Among Asian Americans in the Baltimore-Washington Metropolitan Area, 2009 - 2010 - CDC |
Asian Americans have the highest incidence of hepatocellular carcinoma (HCC), the major form of primary liver cancer, of all ethnic groups in the United States. Chronic hepatitis B virus (HBV) infection is the most common cause of HCC, and as many as 1 in 10 foreign-born Asian Americans are chronically infected with HBV. We tested the effectiveness of a culturally tailored liver cancer education program for increasing screening for HBV among Chinese, Korean, and Vietnamese Americans residing in the Baltimore–Washington metropolitan area, from November 2009 through June 2010. |
| HBV screening rates | 0.386572 |
| cancer education program | 0.420106 |
| baseline HBV screening | 0.394466 |
| control group | 0.53616 |
| intervention group | 0.622634 |
| intervention group participants | 0.340098 |
| liver cancer education | 0.427273 |
| HBV vaccinations | 0.334417 |
| HBV testing | 0.334192 |
| ethnic groups | 0.296833 |
| control groups | 0.313483 |
| 6-month follow-up | 0.303326 |
| Korean Americans | 0.295555 |
| primary liver cancer | 0.35473 |
| control group participants | 0.303864 |
| Asian American Liver | 0.312281 |
| Korean intervention group | 0.308173 |
| chronic HBV infection | 0.411824 |
| Vietnamese Americans | 0.32245 |
| culturally integrated intervention | 0.326395 |
| foreign-born asian americans | 0.411894 |
| Asian Americans | 0.67047 |
| study | 0.357301 |
| United States | 0.386548 |
| HBV prevalence | 0.364371 |
|
| HBV screening test | 0.443643 |
| Baltimore–Washington metropolitan area | 0.427357 |
| HBV serological testing | 0.348788 |
| HBV infection rates | 0.363328 |
| intervention effect | 0.307512 |
| Vietnamese intervention group | 0.308208 |
| HBV vaccination | 0.351504 |
| intervention site | 0.288264 |
| liver education program | 0.288721 |
| effective intervention activities | 0.288596 |
| Chinese Americans | 0.332162 |
| American Liver Cancer | 0.308524 |
| public health | 0.287663 |
| participants | 0.415266 |
| intervention program | 0.321108 |
| educational program | 0.438501 |
| liver cancer prevention | 0.387814 |
| Introduction
Asian Americans | 0.301077 |
| integrated intervention program | 0.305171 |
| HBV screening | 0.903776 |
| HBV slide presentation | 0.346387 |
| HBV infection | 0.637967 |
| liver cancer | 0.741424 |
| liver cancer incidence | 0.309685 |
|
CLICK HERE |
| 11244 |
Centers for Disease Control and Prevention |
Html |
es |
Historias exitosas de PHAde la ATSDR |
La ATSDR analiza si las personas están expuestas a sustancias dañinas y hace recomendaciones para proteger la salud. A menudo esto da lugar a una evaluación de salud pública (PHA, por sus siglas en inglés). |
|
|
CLICK HERE |
| 13070 |
Centers for Disease Control and Prevention |
Video |
en |
Screening for Colorectal Cancer: Optimizing Quality (CME). Primary Care Version Part 2 |
Part 2 of the Primary Care Version CME focuses on why stool blood testing should be offered to patients and the elements of high-quality stool testing, such as selecting an effective test, identifying eligible patients, communicating with patients effectively, high-quality test handling and processing, and ensuring high test completion rates and follow-up after abnormal test results. It is the second of three parts of a continuing education activity that provides guidance and tools for clinicians on the optimal ways to implement screening for colorectal cancer to help ensure that patients receive maximum benefit.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at
http://www.cdc.gov/cancer/videos/colorectal/quality/Primary_Care2/CRC_Screening_Optimizing_Quality_Primary_Care2_256k.mp4 |
| Quality | 0.355409 |
| Colorectal Cancer | 0.945094 |
|
| CME | 0.630822 |
| YouTube | 0.605896 |
|
CLICK HERE |
| 14034 |
Centers for Disease Control and Prevention |
Html |
en |
Physical Activity-Related Policy and Environmental Strategies to Prevent Obesity in Rural Communities: A Systematic Review of the Literature, 2002-2013 |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| worksite policies | 0.455783 |
| physical education | 0.435954 |
| public buildings | 0.440396 |
| adult pa program | 0.438559 |
| PA-related COCOMO strategy | 0.426293 |
| environmental strategies | 0.604399 |
| PA-related COCOMO strategies | 0.531565 |
| environmental changes | 0.427743 |
| Psychosocial Increase | 0.436705 |
| PA program participants | 0.434534 |
| Increase PA opportunities | 0.588463 |
| physical activity–related policy | 0.457763 |
| COCOMO strategy | 0.445282 |
| school | 0.735168 |
| Promote PA resources | 0.464334 |
| increase physical activity | 0.427561 |
| studies | 0.647933 |
| rural areas | 0.518843 |
| studies used strategy | 0.438405 |
| school districts | 0.470028 |
| nutrition-related COCOMO strategies | 0.462541 |
| policy | 0.531181 |
| PE programs | 0.443638 |
| PA opportunities | 0.606491 |
|
| rural communities | 0.826798 |
| common COCOMO strategies | 0.467264 |
| COCOMO strategies | 0.757573 |
| non-COCOMO strategies | 0.588352 |
| community | 0.507781 |
| enhance infrastructure | 0.43004 |
| physical activity | 0.994414 |
| limit sedentary activity | 0.452465 |
| health status | 0.684058 |
| equipment resources | 0.489819 |
| Physical Activity Policy | 0.428106 |
| PA | 0.845583 |
| COCOMO nutrition-related strategies | 0.442092 |
| increase opportunities | 0.426753 |
| PA equipment | 0.578545 |
| extracurricular physical activity | 0.644767 |
| schools | 0.539432 |
| PE | 0.533604 |
| comparison group | 0.480014 |
| screen time | 0.444786 |
| PA resources | 0.49587 |
| physical activity–related COCOMO | 0.447965 |
| largest school district | 0.528536 |
|
CLICK HERE |
| 15600 |
Centers for Disease Control and Prevention |
Html |
en |
The Community Guide - Annual Reports to Congress |
|
| Congress | 0.424242 |
| force evidence-based recommendations | 0.659205 |
| Centers | 0.426346 |
| CDC | 0.477454 |
| related agencies | 0.547137 |
| Patient Protection | 0.565594 |
| findings | 0.425303 |
| stakeholders | 0.434775 |
| yearly reports | 0.551626 |
| constraints | 0.429279 |
| research | 0.424002 |
| Prevention | 0.426265 |
| Disease Control | 0.563776 |
| examination | 0.425675 |
| options | 0.421906 |
| current recommendations | 0.557013 |
| Preventive Services Task | 0.971989 |
| ACA | 0.44041 |
| legislation | 0.424985 |
| Act § 399U | 0.541935 |
|
| preferences | 0.431094 |
| independent Community Preventive | 0.724008 |
| priority areas | 0.555179 |
| available resources | 0.534127 |
| conclusions | 0.433033 |
| Services Task Force | 0.931641 |
| decision makers | 0.536752 |
| mandates | 0.437855 |
| Disclaimer | 0.440404 |
| Affordable Care Act | 0.945338 |
| age groups | 0.547877 |
| CPSTF | 0.470983 |
| gaps | 0.435755 |
| spending | 0.432993 |
| Public Health Service | 0.663937 |
| Community Preventive Services | 0.940468 |
| information | 0.421935 |
| page | 0.421999 |
| constituents | 0.431085 |
|
CLICK HERE |
| 16217 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Fungal Bloodstream InfectionsAssociated with a Compounded Intravenous Medication at anOutpatient Oncology Clinic - New York City, 2016 | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| infection control standards | 0.688827 |
| Pharmacopeial Convention | 0.56621 |
| York State Department | 0.567366 |
| Brendan R. Jackson | 0.540889 |
| Amber M. Vasquez | 0.538556 |
| U.S. Department | 0.532477 |
| New York City | 0.815681 |
| 7Lenox Hill Hospital | 0.541176 |
| 8Northwell Health Laboratories | 0.560012 |
| electronic PDF version | 0.53941 |
| Zoonotic Infectious Diseases | 0.899176 |
| infection prevention standards | 0.560029 |
| Pharmacopeia 39—National Formulary | 0.549419 |
| National Center | 0.663331 |
| U.S. Pharmacopeia chapters | 0.562045 |
| patients | 0.683499 |
| common chemotherapeutic exposure | 0.553045 |
| infected patients | 0.531701 |
| non-Candida species yeast | 0.565203 |
| sterile medication compounding | 0.5691 |
| underlying medical conditions | 0.553715 |
| bloodstream infections | 0.57646 |
| 3New York City | 0.559433 |
| CVC cultures | 0.551063 |
|
| 1Epidemic Intelligence Service | 0.544202 |
| CDC infection control | 0.625441 |
| microbiology record review | 0.556688 |
| screening blood cultures | 0.555677 |
| peripheral line | 0.623329 |
| original MMWR paper | 0.546394 |
| 5Laboratory Leadership Service | 0.543424 |
| dark pigment–forming fungus | 0.565631 |
| MMWR Morb Mortal | 0.54816 |
| Healthcare Quality Promotion | 0.6822 |
| CVC culture | 0.63526 |
| parenteral medication compounding | 0.56675 |
| symptomatic patients | 0.536074 |
| medical record review | 0.56347 |
| vascular access ports | 0.56219 |
| contaminated injectable steroids | 0.713697 |
| central venous catheter | 0.580128 |
| positive culture | 0.737518 |
| York City Department | 0.966361 |
| flush solution | 0.578167 |
| Enteric Diseases | 0.560495 |
| additional patients | 0.549341 |
| E. dermatitidis bloodstream | 0.655698 |
| outpatient oncology | 0.562716 |
|
CLICK HERE |